Mark BOCK,Ming-Hong HAO,Manav KORPAL,Vijay Kumar NYAVANANDI,Xiaoling PUYANG,Susanta SAMAJDAR,Peter Gerard SMITH,John WANG,Guo Zhu ZHENG,Ping ZHU,Lorna Helen MITCHELL,Nicholas LARSEN,Nathalie RIOUX,Sud
申请号：
US15821367
公开号：
US20180141913A1
申请日:
2017.11.22
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration to a subject in need thereof a therapeutically effective amount of the compounds or pharmaceutically acceptable salts thereof. The breast cancer may be an ER-positive breast cancer and/or the subject in need of treatment may express a mutant ER-α protein.
